GLT’s primary function is to carry out innovative, industry–led research and development to provide green and sustainable solutions to industrial problems.
We have developed a fast, simple, and consistent method to generate valuable primary human vascular stem cells from a small, easily obtained sample of human umbilical cord blood.
Titan IC is an innovative technology company leading the way in delivering accelerated search and analytics within high–speed networks and big data worldwide.
CV6 Therapeutics is dedicated to the development of novel innovative therapeutics to improve the lives of patients with cancer and inflammatory diseases.